| Mrs Anne Gurgone, MA, CCC-SLP/L | |
|
200 N Berteau Ave, Elmhurst, IL 60126-2966 | |
| (630) 833-1400 | |
| Not Available |
| Full Name | Mrs Anne Gurgone |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 200 N Berteau Ave, Elmhurst, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043485758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.008560 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Anne Gurgone, MA, CCC-SLP/L 200 N Berteau Ave, Elmhurst, IL 60126-2966 Ph: () - | Mrs Anne Gurgone, MA, CCC-SLP/L 200 N Berteau Ave, Elmhurst, IL 60126-2966 Ph: (630) 833-1400 |
News Archive
The University Jaume I (UJI) has patented a new fluorescent chemical sensor that is capable of detecting citric acid at low concentrations more rapidly and cheaply than the current optical sensors.
St. Jude Medical, Inc. today announced European CE Mark approval and first implants of its Fortify™ and Fortify ST implantable cardioverter defibrillators (ICD) and Unify™ cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S. versions of the Fortify ICD and Unify CRT-D are expected to be launched later this year. The reduced size of these new devices compared to those of previous generations creates the smallest available device footprint in the industry.
Mice without the deoxycytidine kinase (dCK) enzyme have defects in their adaptive immune system, producing very low levels of both T and B lymphocytes, the major players involved in immune response, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
Alexza Pharmaceuticals, Inc. today announced interim results of its Phase 2a study of AZ-002 (Staccato alprazolam) in epilepsy patients. AZ-002 produced a dose-related decrease in mean Standardized Photosensivity Range (SPR), the primary endpoint in the study.
› Verified 3 days ago
Katie Tebrugge, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 606 N Michigan St, Elmhurst, IL 60126 Phone: 630-530-8551 Fax: 630-530-5909 | |
Mrs. Sherry Noel Romano, MHS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 657 S Saylor Ave, Elmhurst, IL 60126 Phone: 773-425-5575 | |
Maison Emily Tollas, MA-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1050 S Euclid Ave, Elmhurst, IL 60126 Phone: 630-333-4343 | |
Georgiann K. Massa, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 410 S Sunnyside Ave, Elmhurst, IL 60126 Phone: 630-833-8614 Fax: 630-833-8650 | |
Danielle Schnieder, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 606 N Michigan St, Elmhurst, IL 60126 Phone: 630-530-8551 Fax: 630-530-5909 | |
Laura R. Natalino-czosnyka, MHS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 S Prospect Ave, Elmhurst, IL 60126 Phone: 630-617-3588 |